valacyclovir hydrochloride

Generic: valacyclovir hydrochloride

Labeler: preferred pharmaceuticals inc.
NDC Directory HUMAN PRESCRIPTION DRUG ANDA Inactive Finished

Drug Facts

Product Profile

Brand Name valacyclovir hydrochloride
Generic Name valacyclovir hydrochloride
Labeler preferred pharmaceuticals inc.
Dosage Form TABLET
Routes
ORAL
Active Ingredients

valacyclovir hydrochloride 500 mg/1

Manufacturer
Preferred Pharmaceuticals Inc.

Identifiers & Regulatory

Product NDC 68788-6896
Product ID 68788-6896_7c60d1d2-a924-4118-9d74-b5c5d0c4d0a9
Product Type HUMAN PRESCRIPTION DRUG
Marketing Category ANDA
Application Number ANDA077135
Listing Expiration 2026-12-31
Marketing Start 2017-02-13

Pharmacologic Class

Classes
dna polymerase inhibitors [moa] herpes simplex virus nucleoside analog dna polymerase inhibitor [epc] herpes zoster virus nucleoside analog dna polymerase inhibitor [epc] herpesvirus nucleoside analog dna polymerase inhibitor [epc] nucleoside analog [ext]

Normalized Code Variants

Searchable formats for this product NDC code

Digits Only 687886896
Hyphenated Format 68788-6896

Supplemental Identifiers

RxCUI
313565
UNII
G447S0T1VC

Resolved Product View

Precedence rule: structured NDC data is preferred, falling back to linked label metadata when unavailable. Source tags show the origin of each value.

Resolved Identity

Brand Name valacyclovir hydrochloride (source: ndc)
Generic Name valacyclovir hydrochloride (source: ndc)
Application Number ANDA077135 (source: ndc)
Routes
ORAL
source: ndc

Resolved Composition

Strengths
  • 500 mg/1
source: ndc
Packaging
  • 10 TABLET in 1 BOTTLE (68788-6896-1)
  • 20 TABLET in 1 BOTTLE (68788-6896-2)
  • 30 TABLET in 1 BOTTLE (68788-6896-3)
  • 4 TABLET in 1 BOTTLE (68788-6896-4)
  • 6 TABLET in 1 BOTTLE (68788-6896-6)
  • 21 TABLET in 1 BOTTLE (68788-6896-7)
source: ndc

Packages (6)

Ingredients (1)

valacyclovir hydrochloride (500 mg/1)

Linked Drug Pages (1)

Raw FDA Data

View complete raw FDA NDC JSON payload
{"route": ["ORAL"], "spl_id": "7c60d1d2-a924-4118-9d74-b5c5d0c4d0a9", "openfda": {"unii": ["G447S0T1VC"], "rxcui": ["313565"], "spl_set_id": ["c153155b-69dc-41b7-91d2-0949ec496174"], "manufacturer_name": ["Preferred Pharmaceuticals Inc."]}, "finished": true, "packaging": [{"sample": false, "description": "10 TABLET in 1 BOTTLE (68788-6896-1)", "package_ndc": "68788-6896-1", "marketing_start_date": "20170213"}, {"sample": false, "description": "20 TABLET in 1 BOTTLE (68788-6896-2)", "package_ndc": "68788-6896-2", "marketing_start_date": "20170213"}, {"sample": false, "description": "30 TABLET in 1 BOTTLE (68788-6896-3)", "package_ndc": "68788-6896-3", "marketing_start_date": "20170213"}, {"sample": false, "description": "4 TABLET in 1 BOTTLE (68788-6896-4)", "package_ndc": "68788-6896-4", "marketing_start_date": "20170213"}, {"sample": false, "description": "6 TABLET in 1 BOTTLE (68788-6896-6)", "package_ndc": "68788-6896-6", "marketing_start_date": "20170213"}, {"sample": false, "description": "21 TABLET in 1 BOTTLE (68788-6896-7)", "package_ndc": "68788-6896-7", "marketing_start_date": "20170213"}], "brand_name": "Valacyclovir hydrochloride", "product_id": "68788-6896_7c60d1d2-a924-4118-9d74-b5c5d0c4d0a9", "dosage_form": "TABLET", "pharm_class": ["DNA Polymerase Inhibitors [MoA]", "Herpes Simplex Virus Nucleoside Analog DNA Polymerase Inhibitor [EPC]", "Herpes Zoster Virus Nucleoside Analog DNA Polymerase Inhibitor [EPC]", "Herpesvirus Nucleoside Analog DNA Polymerase Inhibitor [EPC]", "Nucleoside Analog [EXT]"], "product_ndc": "68788-6896", "generic_name": "Valacyclovir hydrochloride", "labeler_name": "Preferred Pharmaceuticals Inc.", "product_type": "HUMAN PRESCRIPTION DRUG", "brand_name_base": "Valacyclovir hydrochloride", "active_ingredients": [{"name": "VALACYCLOVIR HYDROCHLORIDE", "strength": "500 mg/1"}], "application_number": "ANDA077135", "marketing_category": "ANDA", "marketing_start_date": "20170213", "listing_expiration_date": "20261231"}